These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20408162)

  • 1. A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor.
    Hocke C; Maschauer S; Hübner H; Löber S; Utz W; Kuwert T; Gmeiner P; Prante O
    ChemMedChem; 2010 Jun; 5(6):941-8. PubMed ID: 20408162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor.
    Hocke C; Cumming P; Maschauer S; Kuwert T; Gmeiner P; Prante O
    Nucl Med Biol; 2014 Mar; 41(3):223-8. PubMed ID: 24480780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.
    Nebel N; Maschauer S; Kuwert T; Hocke C; Prante O
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
    Hocke C; Prante O; Salama I; Hübner H; Löber S; Kuwert T; Gmeiner P
    ChemMedChem; 2008 May; 3(5):788-93. PubMed ID: 18306190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
    Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
    J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and radiolabelling by 18F-fluoroarylation of a dopamine D3-selective ligand as prospective imaging probe for PET.
    Höfling SB; Maschauer S; Hübner H; Gmeiner P; Wester HJ; Prante O; Heinrich MR
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6933-7. PubMed ID: 21030255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.
    Leopoldo M; Lacivita E; De Giorgio P; Contino M; Berardi F; Perrone R
    Bioorg Med Chem; 2009 Jan; 17(2):758-66. PubMed ID: 19081257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
    Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and synthesis of an (18) F-labeled dopamine D3 receptor ligand using [(18) F]fluorophenylazocarboxylic tert-butylester.
    Nebel N; Maschauer S; Hocke C; Hübner H; Gmeiner P; Prante O
    J Labelled Comp Radiopharm; 2016 Feb; 59(2):48-53. PubMed ID: 26707848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET.
    Prante O; Tietze R; Hocke C; Löber S; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2008 Mar; 51(6):1800-10. PubMed ID: 18307287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of
    Ji L; Fang Y; Tang J; Liu C; Huang C; Hu Q; Li Q; Chen Z
    Bioorg Med Chem Lett; 2022 Apr; 62():128630. PubMed ID: 35182773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved synthesis of dopamine D2/D3 receptor radioligands [11C]fallypride and [18F]fallypride.
    Gao M; Wang M; Mock BH; Glick-Wilson BE; Yoder KK; Hutchins GD; Zheng QH
    Appl Radiat Isot; 2010 Jun; 68(6):1079-86. PubMed ID: 20167502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M; Renault J; Levoin N; Danvy D; Calmels T; Berrebi-Bertrand I; Robert P; Schwartz JC; Lecomte JM; Uriac P; Capet M
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5376-9. PubMed ID: 20708933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of molecular tools based on the dopamine D
    Stößel A; Brox R; Purkayastha N; Hübner H; Hocke C; Prante O; Gmeiner P
    Bioorg Med Chem; 2017 Jul; 25(13):3491-3499. PubMed ID: 28495386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.
    Grundt P; Prevatt KM; Cao J; Taylor M; Floresca CZ; Choi JK; Jenkins BG; Luedtke RR; Newman AH
    J Med Chem; 2007 Aug; 50(17):4135-46. PubMed ID: 17672446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.